Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel DiseasePaolo Gionchetti, Fernando Rizzello, Vito Annese, et al.
Cancers|October 29, 2025
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter StudyRoberto Mancone, Benedetto Neri, Clara De Francesco, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2009
Internet use among inflammatory bowel disease patients: an Italian multicenter surveyErika Angelucci, Ambrogio Orlando, Sandro Ardizzone, et al.
Expert Opinion on Biological Therapy|September 15, 2021
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from ItalyMichele Francesco Chiappetta, Anna Viola, Mauro Mastronardi, et al.
Inflammatory Bowel Diseases|April 2, 2019
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With InfliximabAgnese Favale, Sara Onali, Flavio Caprioli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
World Journal of Gastroenterology|August 6, 2008
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel diseaseLuciana Rigoli, Claudio Romano, Rosario Alberto Caruso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
United European Gastroenterology Journal|August 11, 2020
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre studyFabio Salvatore Macaluso, Walter Fries, Sara Renna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
Pageof 11